SCHEMBL2352589

SCHEMBL2352589

O=C(C1CCOC1)N(C(=O)[C@@H]1C[C@@H](Cc2ccccc2)CN1)c1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
HRH3 Q9Y5N1 3/20 0.37
OPRM1 P35372 4/20 0.34
CYP2D6 P10635 2/20 0.34
S1PR1 P21453 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.33
NR3C1 P04150 1/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SCN9A Q15858 1/20 0.32
RORC P51449 1/20 0.32
LTA4H P09960 1/20 0.32
EPHX2 P34913 1/20 0.32
CACNA1G O43497 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2352992 0.81 MEN1 (0.37) POLBMEN1KMT2AHRH3OPRM1
SCHEMBL2353030 0.80 OPRM1 (0.37) POLBMEN1KMT2AHRH3OPRM1
SCHEMBL2357176 0.80 HRH3 (0.37) POLBMEN1KMT2AHRH3OPRM1
SCHEMBL2352603 0.79 POLB (0.38) POLBMEN1KMT2AHRH3OPRM1
SCHEMBL2354130 0.79 OPRM1 (0.38) POLBMEN1KMT2AHRH3OPRM1
SCHEMBL2170010 0.78 HTR2C (0.39) SCN9ALTA4H
SCHEMBL2350633 0.77 OPRM1 (0.39) POLBMEN1KMT2AHRH3OPRM1
SCHEMBL2172637 0.75 GSK3A (0.38) POLBMEN1KMT2AHRH3OPRM1
SCHEMBL1371656 0.72 S1PR1 (0.53) POLBMEN1KMT2AHRH3CYP2D6
SCHEMBL2205673 0.71 S1PR1 (0.51) HRH3OPRM1CYP2D6S1PR1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349252-A2 SYNERGISTIC COMBINATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS Exelixis, Inc. (US) 2011-08-03 EP disclosed
WO-2010045601-A2 SYNERGISTIC EFFECTS BETWEEN SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed